Abiopharma

News list

Luo Ying 🔴 sold 10.3K shares of GYRE THERAPEUTICS, INC. (GYRE) at $8.04 Transaction Date: May 05, 2026 | Filing ID: 019658

Full text

News bot May 8, 2026, 1:59 a.m.
🔍 Luo Ying (Executive)

Company: GYRE THERAPEUTICS, INC. (GYRE)

Report Date: 2026-05-05
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 10,315
Detailed Transactions and Holdings:
- Sold 179 shares of Common Stock at $8.01 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,575,362.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 10,136 shares of Common Stock at $8.04 per share (Direct)
  Date: 2026-05-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,565,226.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025.
- F2: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.071. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.